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Abstract 
Introduction: Globally, the use of telestroke programs for acute care are expanding. Currently, 
a standardised set of variables for enabling reliable international comparisons of telestroke 
programs does not exist. This study aimed to establish a consensus-based, minimum data set 
for acute telestroke to enable the reliable comparison of programs, clinical management and 
patient outcomes. 
Methods: An initial scoping review of variables was conducted, supplemented by reaching out 
to colleagues leading some of these programs in different countries. An international expert 
panel of clinicians, researchers, and managers (n=20) from the Australasia Pacific region, 
United States of America, United Kingdom and Europe was convened. A modified-Delphi 
technique was used to achieve consensus via on-line questionnaires, teleconferences and via 
email.  
Results: Overall, 533 variables were initially identified and harmonised into 159 variables for 
the expert panel to review. The final dataset included 110 variables covering three themes 
(service configuration, consultations, patient information) and 12 categories: 1) Details about 
telestroke network/program (n=12), 2) Details about initiating hospital (n=10), 3) Telestroke 
consultation (n=17), 4) Patient characteristics (n=7), 5) Presentation to hospital (n=5), 6) 
General clinical care within first 24 hours (n=10), 7) Thrombolysis treatment (n=10), 8) 
Endovascular treatment (n=13), 9) Neurosurgery treatment (n=8), 10) Processes of care beyond 
24 hours (n=7), 11) Discharge information (n=5), 12) Post-discharge and Follow-up data (n=6). 
Discussion: The acute telestroke minimum dataset provides a recommended set of variables to 
systematically evaluate acute telestroke programs in different countries. Adoption is 
recommended for new and existing services.  
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Introduction 
Around the world, ensuring there is equitable access to best practice acute stroke care is a major 
challenge.1, 2 Innovative models of care are being designed that exploit technology to maximise 
the opportunities to treat patients.3 Telemedicine is an example of how clinical care can be 
facilitated and improved using technology by distributing stroke expertise more effectively, 
through using video consultation to support the examination of patients in locations removed 
from specialist care.4, 5 With telestroke, patients experiencing symptoms have access to a stroke 
medical expert for clinical assessment, confirmation of diagnosis, and establishment of a 
management plan.6  
Various models of telestroke are used in different regions and countries. Telestroke programs 
most commonly exist as either a distributed or a hub-and-spoke model.6 However, currently 
there is no systematic way to compare the effectiveness of these different models. Establishing 
performance measures for telestroke provides the evidence necessary to refine or potentially 
expand such programs, and supports continuous quality improvement activities.6 Further, it has 
been recommended by the American Heart Association/Stroke Association that every 
telestroke network hospital should participate in the collection of data for monitoring the 
quality of stroke care.6 Much duplication can occur in establishing performance measures for 
new programs such as telestroke, and variation in measurement may consequently limit the 
ability to compare services. To enable reliable comparisons of major service features, clinical 
processes and patient outcomes, standardised data collection for telestroke performance should 
be undertaken. Our aim was to establish an international expert consensus minimum dataset 
for acute telestroke (Telestroke Minimum Data Set: TS-MDS).  
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Methods 
The project was led by author Cadilhac and coordinated by the research team based at the 
Florey Institute of Neuroscience and Mental Health (Australia). Following initial meetings 
between leaders of telestroke programs in Australia, Germany, the United States, and United 
Kingdom, it was agreed to progress the initiative of a minimum dataset for acute telestroke. 
We used an iterative process with multiple project phases to identify (phase 1), review (phase 
2) and finalise (phase 3) the variables for the agreed minimum dataset. The methods for each 
phase are outlined in the following sections, with detailed description available in the 
Supplemental file Detailed Methodology. 
 
Phase 1: Identification of potential variables 
Information about telestroke programs was identified from systematic searches of academic 
and grey (e.g., Government health department reports) literature. Data collection tools and data 
dictionaries were sourced directly from established telemedicine networks in Australia 
(Victorian Stroke Telemedicine program),7, 8 Germany (TEMPIS),9 United States of America 
(REACH and STROKE DOC)10, 11 and the United Kingdom (ASTUTE).12 Variables required 
for the evaluation of telestroke programs were identified and summarised into three major 
themes: Service configuration, Consultations, and Patient information. 
 
Phase 2: Review of variable options via modified Delphi technique 
Our modified Delphi technique involved forming an expert panel, by inviting established 
telestroke colleagues and published telestroke clinicians, researchers and/or managers. Two 
rounds of on-line surveys, with iterative teleconferences and document circulation via email to 
review and discuss interim and final results were undertaken. The basic principles for choosing 
the TS-MDS variables was to select those that would be critical to evaluating a telestroke 
program and be meaningful as a collective set. 
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Phase 3: Finalise variables and propose suggested response options  
Once the final TS-MDS variables had been identified from Phase 2, the investigators 
established consensus on wording and variable response options for each variable. This process 
was guided by established data dictionaries for the evaluation of stroke interventions from 
Australia and the USA. The finalised variables have been compiled as part of this publication. 
 
Data management and analysis  
The inclusion criteria or level of concordance was determined by calculating the content 
validity index (CVI) for each item using the following formula: 
CVI = Number of responses at 4 or 5 achieved for the item x    100 
 Total number of responses for the item 
 
Items with an agreement level of less than 50% were identified for exclusion, between 50 and 
79% required additional review, and 80% or more were accepted.13, 14 
 
Results  
Phase 1: Compilation of variable options for the minimum data set 
There were 533 potential variables identified across all sources. Same or similar variables were 
harmonised, with a final set of 159 variables initially covering 11 categories across the three 
major themes. Following the second phase, there were 12 final categories with the inclusion of 
Neurosurgical treatment (detailed below) in the TS-MDS. 
 
Phase 2: Review of variable options 
Delphi Expert Panel 
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There were 23 (14 male, 9 female) invited experts and 20 actively contributed to the panel, 
with a median 7 years (IQR=4.75) telemedicine experience. Panel members’ primary roles 
were 11 clinicians, 7 researchers, and 2 management roles, with 9 panel members reporting 
multiple roles. Panel members were from Australasia (n=6), United States of America (n=7), 
the United Kingdom and Europe (n=7). 
Assessment of concordance 
Results from across the three rounds of review and feedback completed in Phase 2 are 
summarised in Table 1, with final results presented in Table 2. From the first survey, 38% of 
the reviewed variables (n=61) received over 80% concordance, with 28% (n=45) excluded, and 
33% (n=53) requiring further review. Approximately half of these items (n=30, 56%) were 
then accepted after the second survey, 4% (n=2) excluded, and 40% (n=21) required further 
discussion (completed during the teleconference). The expert panel deliberated on variables 
requiring further review, and 86% of these were excluded. However, 14 new variables were 
proposed and agreed to be added including ‘Review of CT completed by telestroke consultant’, 
‘NIHSS score calculated by telestroke consultant’, ‘Real-time audio-visual communication 
used between hospital and telestroke consultant’ and ‘Was other neurosurgical treatment 
recommended’.  
 
Overall, the final variables were grouped in three themes with 12 categories overall, including: 
Telestroke Network/Program and details for the Initiating/Spoke Hospital; Telestroke 
Consultations; and then patient data on Patient characteristics, Presentation to Hospital, 
General Clinical Care within the First 24 hours, Thrombolysis Treatment, Endovascular 
Treatment, Neurosurgery Treatment, Processes of Care Beyond the First 24 Hours, Discharge 
Information and Post-Discharge and Follow-up Data. 
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Phase 3: Final Item Wording and Response Options 
The complete TS-MDS variables and suggested response options are provided in the 
Supplemental file Data Dictionary. There were 110 variables retained for the minimum dataset 
covering the telestroke program, the telestroke consultation and the patient’s clinical 
information.   
1) Telestroke Program/Network (n=12) and Spoke Hospital items (n=10) which provide 
contextual information about the service (Supplemental file Data Dictionary, Section 
1).  
2)  Telestroke Consultation patient items (n=17) which provide information specific to 
each patient’s consultation (Supplemental file Data Dictionary, Section 2). 
3) Patient Data items (n=71) which provides clinical information specific to each patient’s 
presentation, their clinical care and outcomes (Supplemental file Data Dictionary, 
Section 3). 
 
Discussion 
We have developed a minimum dataset for telestroke (TS-MDS) which provides a consensus-
based summary of variables that can be used to monitor and evaluate acute telestroke services 
in different countries. The final set of variables enables comparisons of consultations, clinical 
care processes and patient outcomes for new or existing services. Overall, we discarded ~40% 
of the original variables identified following harmonisation and prioritising those considered 
of utmost importance to collect. The final set of variables was dominated by those used to 
describe patients and the care they receive (>65%).  
 
We recognise that, depending upon the resources available to programs, it may be impractical 
to collect all variables within the TS-MDS. Complete patient episode care data may be in 
multiple locations (e.g., if patient transferred for treatment). Thus, the time required to collect 
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these data is anticipated to range between 30-40 minutes, but will vary considerably. For 
example, depending on each service’s acute and patient follow-up data collection systems 
currently in place (e.g., exporting from established administration data sets would reduce time, 
if teleconsultation part of medical record), and each patient episode (i.e., smaller data collection 
if not thrombolysed or neurosurgery treatment not undertaken). Recommendations for response 
options may be more extensive than currently presented, or the frequency or capacity for 
collecting outcomes may differ. The majority of items and response options have been collated 
from established data collection procedures and published program evaluations, however, 
reliability of the complete data set can be examined in future as services across countries begin 
to use the TS-MDS. Services are encouraged to provide feedback to the first author. 
Nevertheless, following the guidance we have provided will ensure more reliable mapping of 
variables across programs and the ability to pool data from different programs. 
 
It will be important to consider how different models of providing telestroke influence 
comparisons of patient and consultation data. Therefore, each aspect of telestroke programs 
(i.e., service configuration, consultations and patient information) remain important to collect. 
In practical terms, variables pertaining to the Telestroke program/network and the Initiating 
(spoke) hospitals (i.e., service configuration) could be collected every 2 years as these are 
unlikely to change regularly. However, variables related to the telestroke consultation and 
patient should be collected continuously. Additional variables can be collected as required or 
relevant, at the discretion of each program.  
 
Some services may be specifically interested in one aspect of the telestroke consultations and 
include additional items in their data collection. There may also be merit in collecting other 
variables related to telemedicine training and skills. For example, there is a recognised 
importance of integrating telestroke training into supervised neurovascular fellowships to 
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increase proficiency and enable benchmarking prior to independent practice in telestroke.15 
Information such as when a program commenced, type of payments or reimbursements, 
technical support the program receives, type of equipment/software, and whether a program 
was co-designed with patients may also be relevant. However, we consider these aspects to 
cover very focussed aspects of telemedicine services that extend beyond the basic ‘usual’ 
clinical practice monitoring of service quality and outcomes. 
 
While choice in use of all or some of these variables may occur, this minimum dataset can be 
considered a baseline for consideration and reporting. We believe that, as a minimum, the 
service configuration variables for each program should be reported within the first 2-5 years 
of operation and consultation data that includes sufficient patient information to describe the 
population and treatments received. The type of video-based activations versus phone or the 
number of technical incidents that precluded video-based consultation for each patient may 
also be relevant to collect for monitoring service performance, but these quality assurance 
metrics have not been recommended here. As an alternative, these aspects are broadly covered 
in the service configuration reporting. Where possible, 90-day health outcome data should be 
reported (especially the modified Rankin score). Data linkage may also enable more patient 
information to be captured without having to duplicate effort and waste resources in collecting 
information for different purposes.16 Within Australia, the Victorian Stroke Telemedicine 
Program will include regular linkage between the Consultation data captured as part of the 
telestroke program, and data collected through the Australian Stroke Clinical Registry and 
Ambulance Victoria systems. This linkage will allow confirmation of treatment received in 
hospital and 90-day outcomes.17, 18 The dataset may require modification to accommodate pre-
hospital telestroke consultations. 
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Creating a database for the collection of these variables was beyond the scope of this work but 
details from within the Data Dictionary can be used to form part of future development 
initiatives. It may also be relevant for stroke quality of care registries, such as the Registry of 
Stroke Care Quality (RES.Q) developed under the European Stroke Organisation (https://eso-
stroke.org/res-q/) to incorporate these variables for routine collection. Other practical aspects 
such as recommendations for agreements to enable sharing data were also beyond the scope of 
this initial work. However, submission of anonymised data into a VISTA (Virtual International 
Stroke Trials Archive)19, 20 for telestroke could be a future option. There is growing momentum 
to ensure everyday clinical practice data are made available for secondary purposes so that we 
maximise uses and avoid data waste.16, 21 The development of the TS-MDS supports such future 
endeavours. 
 
Strengths and limitations 
We undertook an iterative and inclusive process for receiving feedback. We also searched grey 
and published literature, as well as obtaining data collection forms from telestroke programs to 
ensure our initial list of variables was extensive. Reassuringly, when these variables were 
harmonised the number of variables was able to be reduced significantly, highlighting that 
many of the variables were already being collected across programs.  
 
For the purposes of developing this TS-MDS, the invited experts were deemed to be a 
representative panel in the field of stroke and telestroke internationally. The Delphi process is 
not reliant on a large sample size of experts, but one in which consensus and saturation of 
information can be reached. Panel size recommendations range from 5-1022, 10-1523, 15-2024 
members, dependent upon ensuring representative judgements on the target issue.25 Our panel 
was at the upper range, but incorporated clinicians, managers and researchers. The 
recommended level of concordance also varies in the published literature from 66%26, 75%27 
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or no less than 78%.22 We used 80% as the threshold for concordance and to indicate retention 
of a variable, which was consistent with similar research using panels of experts.13, 14 
 
Finally, as with many aspects of medicine, advances in stroke care will mean we need to 
consider regular reviews of the agreed variables. We also recognise that mode of transport may 
be an important area for future research28, 29 and have included options to collect that data. 
As experienced during this study, the advent of endovascular thrombectomy (EVT)30, 31 
becoming routine practice, extended time windows for treatment32 and greater options for 
neurosurgical intervention meant the addition of extra variables late in the process of Phase 2. 
We believe this final set of variables is sufficiently robust to cover the major contemporary 
aspects of acute telestroke care operating in developed countries, with future work required to 
identify relevant variables for under developed or developing nations.3 
 
Conclusions 
The consensus-based, acute telestroke minimum dataset presented in this paper provides a 
recommended set of variables to evaluate acute telestroke programs in different locations. This 
information may be useful for new or existing services seeking to monitor their practice or 
reliably benchmark their quality of care with other telestroke services. 
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Table 1. Results from the three rounds of review within Phase 2, by minimum data set category and total 
Category 
Initial number 
of variables 
Survey 1 Survey 2 Teleconferences and review# 
Final number 
of variables# 
<50% 
50-
79%* 
>80% <50% 
50-
79%** 
>80% Accepted Excluded 
Service configuration           
Details of telestroke 
network/programs 
8 0 5 3 0 2 3 
2 + 1 new + 1 
split 
0 12 
Details about initiating 
hospital 
6 0 1 5 0 1 0 1 + 4 new 0 10  
Telestroke consultation 14 1 2 11 0 2 0 3 new 2 17 
Patient information           
Characteristics 15 7 6 2 0 1 5 0 1 7 
Presentation to hospital 26 9 9 8 0 4 5 0 4 5 
Hyperacute care           
Thrombolysis treatment 12 3 3 6 1 1 1 0 1 10 
Endovascular treatment 12 0 1 11 0 0 1 0 0 13 
Neurosurgery Treatment## - - - - - - - 7 new 0 8 
General clinical care within 
first 24 hours 
25 7 9 9 1 5 3 0 5 10 
Processes of care beyond first 
24 hours 
18 8 8 2 0 3 5 0 3 7 
Discharge information 11 5 2 4 0 1 1 0 1 5 
Post-discharge and Follow-up 
data 
12 5 7 0 0 1 6 0 1 6 
TOTAL 159 
45 
(28%) 
53 
(33%) 
61 
(38%) 
2 (4%) 
21 
(40%) 
30 
(56%) 
3 (14%) +16 
new/split 
18 (86%) 110 Total 
New indicates variable was not part of initial pool identified and added during review process. Split indicates variable that  
#Final numbers may vary across categories due to items changing categories throughout the consensus process. The final number of variables is the outcome of the 
full iterative process. 
##Additional category added during teleconference.  
 
17 
 
 
Table 2. Categories, final number of variables and example questions for the International Telestroke Minimum 
Dataset 
Categories 
Number of 
variables 
Examples 
Service configuration (N=22)   
Details of telestroke network/programs 12 Hub-and-spoke, distributed, for profit or not 
Details of initiating hospital 10 Hours of operation, stroke unit availability 
Telestroke consultation (N=17) 17 Mode, reason, date and time, duration, imaging review 
Patient information (N=71)   
Characteristics 7 Age, sex, stroke history 
Presentation to hospital 5 Arrived by ambulance, time of arrival 
Hyperacute care   
Thrombolysis treatment 10 Thrombolysis recommended, date/time treatment 
Endovascular treatment 13 Endovascular treatment recommended 
Neurosurgery treatment 8 Type of neurosurgery, date/time treatment  
General clinical care within first 24 hours 10 Stroke symptom onset, CT time 
Processes of care beyond first 24 hours 7 Follow-up CT, sICH, stroke unit stay 
Discharge information 5 Discharge diagnosis, destination 
Post-discharge and follow-up 6 Time point, residence, mRS 
Total 110  
Note: CT=computed tomography scan, sICH=symptomatic intracerebral haemorrhage, mRS= modified 
Rankin Scale 
 
 
